Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
19
-
Total 13F shares, excl. options
-
1.2M
-
Shares change
-
-577K
-
Total reported value, excl. options
-
$1.49M
-
Value change
-
-$493K
-
Number of buys
-
9
-
Number of sells
-
-7
-
Price
-
$1.25
Significant Holders of Lexaria Bioscience Corp. - COM NEW (LEXX) as of Q4 2023
22 filings reported holding LEXX - Lexaria Bioscience Corp. - COM NEW as of Q4 2023.
Lexaria Bioscience Corp. - COM NEW (LEXX) has 19 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.2M shares
.
Largest 10 shareholders include Invenomic Capital Management LP (732K shares), COWEN AND COMPANY, LLC (256K shares), Connective Capital Management, LLC (60K shares), GEODE CAPITAL MANAGEMENT, LLC (53.6K shares), VANGUARD GROUP INC (46.2K shares), CITADEL ADVISORS LLC (29.6K shares), Tower Research Capital LLC (TRC) (5.81K shares), UBS Group AG (4.53K shares), 1832 Asset Management L.P. (2.69K shares), and ADAR1 Capital Management, LLC (1.63K shares).
This table shows the top 19 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.